Anna Pasechnek

Anna Pasechnek has worked in the scientific field for the past two years. Anna began their career in 2020 as the Scientific Director and Clinical Manager at MYOR. In 2022, they moved to FutuRx, where they currently serve as a Scientist at A2i Therapeutics ltd.

Anna Pasechnek received their Doctor of Philosophy - PhD from Tel Aviv University in 2019, with a field of study in Interactions between pathogenic bacteria and its viruses. Anna also received their Master of Science (M.Sc.) from Tel Aviv University in 2008, with a field of study in Microbiology, General.